Preventing and Treating Lymphedema

In developed countries, secondary lymphedema is most commonly associated with cancer treatment. Ongoing clinical trials across various cancer types aim to optimise nodal treatment approaches, acknowledging that extensive nodal removal often doesn’t significantly improve long-term survival. To address this, there’s a pressing need for widespread adoption of proactive lymphedema screening models and consistent patient education to enhance awareness and early intervention in high-risk individuals. Promising advancements in microsurgery for both preventing and treating lymphedema are actively under investigation, offering potential long-term therapeutic options.